TNFRSF1A and Parkinson disease: In the present study, the long-term blockade of TNF-TNFR1 signaling did not affect the age at PD onset, implying limited potential for TNF inhibitors to affect PD progression (while keeping the aforementioned caveats about interpreting genetic vs pharmacologic results in mind).